Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Insights
  3. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Pharmaceutical Manufacturers
  • Hospital and Healthcare Providers
  • Pharmacy
  • Governments
  • Private Payers and Insurers
  • Academics and Researchers
Pharmaceutical Manufacturers

Leveraging the power of the IQVIA CORE, we support Canada’s pharmaceutical manufacturers as they invest in, and advance, human health. We do this via breakthroughs in insights, technology, analytics and human intelligence that bring the progress in data science together with the possibilities of human science.

Learn More
PHARMACEUTICAL MANUFACTURERS QUICK LINKS
Hospital and Healthcare Providers

Hospitals and healthcare providers are looking for cutting-edge decision support to augment their strategy and performance so they can focus on delivering high quality value to patients. As the Human Data Science Company, IQVIA is uniquely positioned to provide actionable data, innovative technology, and expertise customized to the hospital and provider community.

Learn More
Pharmacy

A specialized division of IQVIA (Canada), Health Industry Information Services (HIIS) serves the precise needs of non-pharmaceutical healthcare stakeholders including Retail Pharmacy, Independent Pharmacy, and Specialty Pharmacy.

Learn More
PHARMACY QUICK LINKS
Governments

Almost everything we do is powered by the IQVIA CORE. This holistic approach allows us to use Human Data Science to create integrated solutions for our customers.

Learn More
Private Payers and Insurers

Health benefit analytics for effective response to market changes.

Learn More
Academics and Researchers

Take your research further. Data assets that allow you to explore new areas in inquiry that can advance public health efforts. IQVIA supports the Canadian research community and has responded to hundreds of requests to support new areas of inquiry.

Learn More
MAIN/Insights
Insights/
INSIGHTS

Explore our library of resources spanning the healthcare ecosystem. Hear from IQVIA data scientists, doctors, researchers, and other experts on the topics, trends, and market developments that matter to you.

Learn More
PHARMACEUTICAL TRENDS

Media representatives and other industry stakeholders can access current and historical top-line Canada and global pharmaceutical trends for use in story development or vital health research.

Learn More

WEBINARS

"View our on-demand and upcoming webinars.

Learn More
MAIN/Contact Us
Contact Us/
Fact Sheet
Trends in the use of medications for the treatment of Attention Deficit Disorder with or without Hyperactivity in Canada, 2019–2022
IQVIA Snapshot - Prevalence and Treatment of Mental Health Disorders
Feb 16, 2024

Get instant access

Download
This Snapshot presents a few highlights taken from the Dashboard on the use of medications for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children, adolescents, and adults, which is characterized by the presence of various manifestations, including excessive inattention, hyperactivity, and impulsive behaviours. The prevalence and demographic characteristics of consumption in the general Canadian population are presented for 2019, 2020, 2021, and 2022.

You may also be interested in

Fact Sheet
Trends in the use of antidepressants and anxiolytics in Canada, 2019–2022
White Paper
Medication Treatments for Mental Health Disorders in Canada
White Paper
Prescription Opioid Trends in Canada
Fact Sheet
Location Reports Pharmacies
Fact Sheet
$name
Fact Sheet
$name
Prev
Next
Contact Us